Rheumnow Podcast cover image

EULAR 2023 Lupus Highlights

Rheumnow Podcast

00:00

Barry Sittenib: A Randomized Control Trial for Non-Renal Lupus

Barry Sittenib is a Jack Inibitter in treating active lupus nephritis. The primary endpoint for this study was reduction of a proteinuria of more than 50% from baseline. There was no significant difference compared to what already known in terms of side effect for Barry Sittenib because the number is quite small.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app